ArticleTranslational cancer research2026

Neoadjuvant androgen deprivation therapy with bicalutamide compared to hormonal agents in treating high-risk prostate cancer: a real-world cohort study.

Jia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.